📣 VC round data is live. Check it out!
- Public Comps
- PROCEPT BioRobotics
PROCEPT BioRobotics Valuation Multiples
Discover revenue and EBITDA valuation multiples for PROCEPT BioRobotics and similar public comparables like Staar Surgical, Poly Medicure, Oxford Nanopore Technologies, Heron Neutron Medical and more.
PROCEPT BioRobotics Overview
About PROCEPT BioRobotics
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Founded
2021
HQ

Employees
756
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialPROCEPT BioRobotics Financials
PROCEPT BioRobotics reported last 12-month revenue of $343M and negative EBITDA of ($40M).
In the same LTM period, PROCEPT BioRobotics generated $221M in gross profit, ($40M) in EBITDA losses, and had net loss of ($92M).
Revenue (LTM)
PROCEPT BioRobotics P&L
In the most recent fiscal year, PROCEPT BioRobotics reported revenue of $308M and EBITDA of ($50M).
PROCEPT BioRobotics is unprofitable as of last fiscal year, with gross margin of 64%, EBITDA margin of (16%), and net margin of (31%).
Financial data powered by Morningstar, Inc.
PROCEPT BioRobotics Stock Performance
PROCEPT BioRobotics has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
PROCEPT BioRobotics' stock price is $28.90.
PROCEPT BioRobotics share price increased by 20.2% in the last 30 days, and decreased by 50.2% in the last year.
PROCEPT BioRobotics has an EPS (earnings per share) of $-1.68.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | 2.9% | 20.2% | 27.4% | -50.2% | $-1.68 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPROCEPT BioRobotics Valuation Multiples
PROCEPT BioRobotics trades at 4.3x EV/Revenue multiple, and (36.5x) EV/EBITDA.
EV / Revenue (LTM)
PROCEPT BioRobotics Financial Valuation Multiples
As of May 22, 2026, PROCEPT BioRobotics has market cap of $2B and EV of $1B.
PROCEPT BioRobotics has a P/E ratio of (17.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PROCEPT BioRobotics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


PROCEPT BioRobotics Margins & Growth Rates
PROCEPT BioRobotics grew revenue by 30% but EBITDA decreased by 50% in the last fiscal year.
In the most recent fiscal year, PROCEPT BioRobotics reported gross margin of 64%, EBITDA margin of (16%), and net margin of (31%).
PROCEPT BioRobotics Margins
PROCEPT BioRobotics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
PROCEPT BioRobotics Operational KPIs
PROCEPT BioRobotics' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.4M for the same period.
PROCEPT BioRobotics' Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
PROCEPT BioRobotics' Rule of X is 67% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
PROCEPT BioRobotics Competitors
PROCEPT BioRobotics competitors include Staar Surgical, Poly Medicure, Oxford Nanopore Technologies, Heron Neutron Medical, Qingdao Baheal Medical, Vitrolife, Cofoe Medical, Weigao Group, Haier Biomedical and Embla Medical.
Most PROCEPT BioRobotics public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.5x | 5.5x | 27.6x | 87.6x | |||
| 7.8x | 7.6x | 27.2x | 31.8x | |||
| 4.3x | 4.0x | (11.2x) | (12.9x) | |||
| 3867.2x | — | (90.4x) | — | |||
| 1.7x | 1.6x | 13.4x | 13.4x | |||
| 4.3x | 4.3x | 14.8x | 14.5x | |||
| 2.7x | 2.5x | 14.4x | 13.7x | |||
| 5.9x | 5.6x | 16.9x | 17.4x | |||
This data is available for Pro users. Sign up to see all PROCEPT BioRobotics competitors and their valuation data. Start Free Trial | ||||||
PROCEPT BioRobotics Funding History
Before going public, PROCEPT BioRobotics raised $503M in total equity funding, across 6 rounds.
Last private valuation of PROCEPT BioRobotics was $873M, after raising $85M in June 2021 from CPMG, Duquesne Family Office, Fidelity, and 3 other investors.
PROCEPT BioRobotics Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PROCEPT BioRobotics
| When was PROCEPT BioRobotics founded? | PROCEPT BioRobotics was founded in 2021. |
| Where is PROCEPT BioRobotics headquartered? | PROCEPT BioRobotics is headquartered in United States. |
| How many employees does PROCEPT BioRobotics have? | As of today, PROCEPT BioRobotics has over 756 employees. |
| Who is the CEO of PROCEPT BioRobotics? | PROCEPT BioRobotics' CEO is Larry L. Wood. |
| Is PROCEPT BioRobotics publicly listed? | Yes, PROCEPT BioRobotics is a public company listed on Nasdaq. |
| What is the stock symbol of PROCEPT BioRobotics? | PROCEPT BioRobotics trades under PRCT ticker. |
| When did PROCEPT BioRobotics go public? | PROCEPT BioRobotics went public in 2021. |
| Who are competitors of PROCEPT BioRobotics? | PROCEPT BioRobotics main competitors include Staar Surgical, Poly Medicure, Oxford Nanopore Technologies, Heron Neutron Medical, Qingdao Baheal Medical, Vitrolife, Cofoe Medical, Weigao Group, Haier Biomedical, Embla Medical. |
| What is the current market cap of PROCEPT BioRobotics? | PROCEPT BioRobotics' current market cap is $2B. |
| What is the current revenue of PROCEPT BioRobotics? | PROCEPT BioRobotics' last 12 months revenue is $343M. |
| What is the current revenue growth of PROCEPT BioRobotics? | PROCEPT BioRobotics revenue growth (NTM/LTM) is 27%. |
| What is the current EV/Revenue multiple of PROCEPT BioRobotics? | Current revenue multiple of PROCEPT BioRobotics is 4.3x. |
| Is PROCEPT BioRobotics profitable? | No, PROCEPT BioRobotics is not profitable. |
| What is the current EBITDA of PROCEPT BioRobotics? | PROCEPT BioRobotics has negative EBITDA and is not profitable. |
| What is PROCEPT BioRobotics' EBITDA margin? | PROCEPT BioRobotics' last 12 months EBITDA margin is (12%). |
| What is the current EV/EBITDA multiple of PROCEPT BioRobotics? | Current EBITDA multiple of PROCEPT BioRobotics is (36.5x). |
| What is the current FCF of PROCEPT BioRobotics? | PROCEPT BioRobotics' last 12 months FCF is ($34M). |
| What is PROCEPT BioRobotics' FCF margin? | PROCEPT BioRobotics' last 12 months FCF margin is (10%). |
| What is the current EV/FCF multiple of PROCEPT BioRobotics? | Current FCF multiple of PROCEPT BioRobotics is (43.2x). |
| How many companies PROCEPT BioRobotics has acquired to date? | PROCEPT BioRobotics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies PROCEPT BioRobotics has invested to date? | PROCEPT BioRobotics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to PROCEPT BioRobotics
Lists including PROCEPT BioRobotics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.